Related Experiment Video
Updated: May 7, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Oxaliplatin complexes with carnosine and its derivatives: in vitro cytotoxicity, mass spectrometric and computational
Eslam M Moustafa1, Claire L Camp, Ahmed S Youssef
1Department of Chemistry, The American University in Cairo, New Cairo 11835, Egypt. T.Shoeib@aucegypt.edu.
Abstract:
The complexation of the Pt-based anti-cancer drug oxaliplatin (OxPt) with biological ligands other than DNA is believed to be a major cellular sink for the drug reducing its therapeutic potential and acting as a potential cause of toxicity. In this paper, the very first hypothesis driven investigation of the role of the naturally abundant cytoplasmic dipeptide ligand β-alanyl-l-histidine dipeptide (carnosine) in OxPt detoxification is presented. In vitro studies on hepatocellular carcinoma HepG2 cells suggest that carnosine may inhibit the cytotoxic action of OxPt most likely through the formation of complexes that are less cytotoxic than OxPt alone. Evidence is provided to suggest that pre-exposure of HepG2 cells to elevated levels of carnosine appears to have a lasting effect on reducing the cytotoxicity of OxPt even after the removal of the externally added carnosine. This effect, however, is likely under kinetic control as its magnitude was shown not to vary significantly with the level of carnosine exposure within the concentration range used in this study. Various mass spectrometry techniques employing electrospray ionization and chip nanospray were employed to study the interaction of oxaliplatin with carnosine as well as two of its derivatives β-alanyl-N-methylhistidine (anserine) and N-acetylcarnosine (NAC). Evidence of complexation between OxPt and each of the three ligands examined is presented. Most species observed were unambiguously assigned and compared to their theoretical isotopic patterns. Common fragmentation products due to the collisionally-activated protonated complexes of each of the ligands examined with OxPt, [M + OxPt + H](+), where M = carnosine, anserine or NAC, were reported. Density functional calculations at the B3LYP/LANL2DZ level were used to obtain structural information and relative free energies of different isomers of the observed precursor [Carnosine + OxPt + H](+) both in the gas phase and in solution as well as to probe its fragmentation, highlighting plausible fragmentation mechanisms that account for all the experimental results. Data are presented to show several binding modes between electron rich sites such as N and O centers of carnosine and the Pt metal of OxPt. Calculations were also employed to obtain proton affinities and free energies of key reactions. The proton affinities of carnosine, anserine and NAC at 298 K were calculated to be 254.4, 255.9 and 250.2 kcal mol(-1) respectively. To the best of our knowledge the proton affinities of anserine and N-acetyl-carnosine are the first reported values in the literature.
Insights
The dipeptide carnosine may reduce the toxicity of the chemotherapy drug oxaliplatin (OxPt) by forming less harmful complexes. This protective effect in liver cancer cells appears lasting, even after carnosine removal.
Area of Science:
- Biochemistry
- Pharmacology
- Computational Chemistry
Background:
- Oxaliplatin (OxPt) is a platinum-based chemotherapy drug whose efficacy is limited by complexation with biological molecules, leading to reduced therapeutic potential and increased toxicity.
- Cytoplasmic dipeptides, such as carnosine (β-alanyl-l-histidine), are naturally abundant and may play a role in drug detoxification.
- Understanding OxPt's interactions with non-DNA ligands is crucial for improving cancer treatment strategies.
Purpose of the Study:
- To investigate the role of carnosine in the detoxification of oxaliplatin (OxPt).
- To explore the complexation of OxPt with carnosine and its derivatives (anserine, N-acetylcarnosine).
- To elucidate the binding modes and fragmentation mechanisms of OxPt-ligand complexes using experimental and computational methods.
Main Methods:
- In vitro studies using hepatocellular carcinoma HepG2 cells to assess carnosine's effect on OxPt cytotoxicity.
- Mass spectrometry techniques (electrospray ionization, chip nanospray) to analyze OxPt-ligand interactions and complex formation.
- Density functional theory (DFT) calculations (B3LYP/LANL2DZ) to determine structural, energetic, and fragmentation properties of complexes.
Main Results:
- Carnosine significantly inhibits the cytotoxic action of OxPt in HepG2 cells, likely by forming less cytotoxic complexes.
- Pre-exposure to carnosine confers a lasting protective effect against OxPt cytotoxicity, suggesting a kinetically controlled mechanism.
- Mass spectrometry confirmed complexation between OxPt and carnosine, anserine, and N-acetylcarnosine, with DFT calculations providing insights into binding modes and fragmentation pathways.
Conclusions:
- Carnosine acts as a potential endogenous scavenger for oxaliplatin, mitigating its toxicity through complex formation.
- The interaction between OxPt and carnosine is complex, involving binding to electron-rich nitrogen and oxygen centers.
- Calculated proton affinities for carnosine, anserine, and N-acetylcarnosine provide valuable thermodynamic data for understanding their chemical behavior.
Related Concept Videos
Complexometric Titration: Ligands
Complexation Equilibria: The Chelate Effect
EDTA: Chemistry and Properties
Complexation Equilibria: Factors Influencing Stability of Complexes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
EDTA: Auxiliary Complexing Reagents
